Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Montmorillonite

Generic Name: Montmorillonite

Drug Type: Small Molecule

Chemical Formula: Al_₂H_₂O_₁₂Si_₄

CAS Number: 1318-93-0

Unique Ingredient Identifier: A585MN1H2L

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

Acute Diarrhea
Chronic Functional Diarrhea

Clinical Trials

A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population

Early Phase 1

Not yet recruiting

Posted: 2024/09/09

Sponsor:

Combined Military Ho...

ID:NCT06588036

Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects

Phase 1

Completed

Posted: 2022/02/23

Sponsor:Jiangsu HengRui Medi...

ID:NCT05252546

Evaluation of Smectite Effect As A Food Thickener On Gastroesophageal Reflux Disease In Neonates Using Combined Esophageal Multichannel Intraluminal Impedance

Phase 4

Completed

Posted: 2021/03/09

Sponsor:Ain Shams Maternity ...

ID:NCT04788485

The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19

Phase 4

Completed

Posted: 2020/07/21

Sponsor:Chinese Medical Asso...

ID:NCT04479202

Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea

Phase 1

Completed

Posted: 2017/02/08

Sponsor:Ipsen

ID:NCT03045926

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

SMECTA SACHET 3 g/sachet

Manufacturer:BEAUFOUR IPSEN INDUSTRIE

Form:POWDER

Strength:3g/sachet

Online:Yes

Approved: 1991/07/03

Approval:SIN06338P

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy